🔗 Share this article

A shadow economy for unlicensed slimming medications is propelled by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Experimental Drug Acquiring Traction Online

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its supposed weight-reducing effects. Followers are encouraged to message these accounts privately for source information, while also receiving promotional offers.

Active Commerce on Social Networks

Separately, a robust trade exists on messaging services, where groups with thousands of members share “before and after” images, injection guides and claims of rapid British shipping. Sellers promote the drug there before redirecting customers to other platforms for purchases.

Learning About The Experimental Drug

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Professionals Voice Worries

Nevertheless, doctors and pharmacists have cautions that the sale of what remains an unlicensed drug in the UK is a cause for concern and could result in users administering products of unknown origin.

Some professionals said the popularity for retatrutide could be linked to the increasing cost of approved weight loss treatments such as Mounjaro.

Legal Status and Enforcement

Selling the unapproved drug on social media or Telegram is illegal in the UK, as it is an unapproved drug that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several content creators attempt to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still violate pharmaceutical, marketing, and customer regulations, risking penalties, prosecution or prison.

Platform Reaction and Content Elimination

Based on the social media company, the service has removed violative content and prohibited associated keywords and search suggestions. The company said it was committed to keeping the platform safe and investing in enhancing compliance measures.

Digital Marketplace Operations

Research also found communities with up to 9,000 participants selling retatrutide using the platform's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly displays channels with thousands of users, filled with photos of slimming results, glowing reviews and detailed instructions for mixing or administering at residence.

After minutes of joining one group, a vendor posted WhatsApp details, where the majority of transactions take place. The vendor sent an instruction manual and promised delivery within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about weight, medical conditions or previous experience.

Item Information and Costs

Within these communities, posts display black plastic parcels with Royal Mail labels, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at home with purified liquid, or pre-filled injectors usually priced at £160 for 20 milligrams. When asked how much time a pen should be used, vendors give conflicting responses varying between a several days to “depends on your body”.

Service Moderation and Safety Actions

A representative for the messaging service stated it actively moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering substances they can’t verify. Although the science behind retatrutide is sound, these online versions may not contain what they claim,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With costs rising, patients are using online platforms. But counterfeit treatments are highly dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she said.

Her team has already seen patients harmed by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for human use,” they said, adding that any product “falsely representing itself as a company investigational substance not yet authorized … may expose patients to possibly serious medical dangers”.